Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Study reveals SARS-CoV-2 prevents the formation of new red blood cells

Does microbe in the gut protect against hazardous exposure ?

AIIMS Delhi Excellence On Cancer Research Project Recruitment

Study reveals SARS-CoV-2 prevents the formation of new red blood cells
  • BiotechToday
  • World

Study reveals SARS-CoV-2 prevents the formation of new red blood cells

bioxone November 4, 2020November 3, 2020

Sumedha Guha, Techno India University

In a recent study conducted on lung samples obtained from 79 patients who died of COVID-19, researchers from the Far Eastern Federal University in Russia discovered the SARS-CoV-2 virus can not only damage red blood cells (RBCs) but also prevent the new formation of key red blood cells (namely, Erythrocytes). 

Based on initial studies, the team of researchers along with their colleagues in Japan have revealed they are assuming the main target for the virus is the red bone marrow. Here it damages the endothelium – the tissue which in healthy individuals regulates the migration of matured erythrocytes into the bloodstream. They added that the early breakdown of RBCs is the initial reaction of the body against the SARS-CoV-2 virus. This breakdown scales up gradually. The patient may notice a taste of iron in their mouths. This occurs because the Haemoglobin pigment that is carried by the erythrocytes gets released from the damaged red blood cell and into the saliva.

The loss of erythrocytes would gradually lead to damage to blood vessels, internal organs, and neuronal networks in the brain due to a lack in supply of arterial oxygen to them. In severe cases, multiple organ failure is also a grave possibility.

All people with low Haemoglobin are at risk of developing these complications. This includes elderly people above the age of 60, people having high blood pressure, obese individuals, diabetes patients, pregnant women, primary and acquired immunodeficiency patients, HIV and cancer patients.

In this scenario, artificial ventilation is not a solution, as the transporter of oxygen in the body, the Haemoglobin pigment (inside the erythrocytes) is getting degraded due to damage of erythrocytes.

The researchers have concluded that effective therapy options for such patients include administration of Vitamin B12 and erythrocyte mass.

Also read: ConCysFind – Easing the identification of preserved AA based on phylogenetic occurrence

Source: https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/covid-virus-may-block-formation-of-key-red-blood-cells/articleshow/78991595.cms

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged asthma cancer CORONAVIRUS COVID-19 Diabetes diarrhoea erythrocytes fever HIV immunodeficiency Obesity pandemic SARS-CoV-2 virology Vitamin B12 vitamins

One thought on “Study reveals SARS-CoV-2 prevents the formation of new red blood cells”

  1. Pingback: Tumorigenic Transformation of Stem Cells can cause Cancers - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

AIIMS Delhi Excellence On Cancer Research Project Recruitment

bioxone November 4, 2020

-Shristi Sharma, Team bioXone AIIMS Delhi Bioinformatics, Biotech, Life Science JRF Job. Junior Research Fellow Job Opening for MTech Biotech/Bioinformatics, MSc Biotech/Biochem/ Zoology/ Biophysics/Life Sciences applicants. Interested and eligible applicants can check out all of the details on the same below:  Name of the Post: Junior Research Fellow No. of Posts: 01 Name of the […]

Related Post

  • BiotechToday
  • World

Da Vinci Family Tree: An intriguing DNA project!

BioTech Today July 12, 2021July 11, 2021

Sarah Khatkhatay, SK Somaiya, Vidhyadhar Leonardo Da Vinci was a true genius who graced the world with his presence and left a significant heritage not only in the world of art but in science as well. After putting in relentless efforts on studying and analysing Leonardo Da Vinci’s DNA, Alessandro Vezzosi and Agnese Sabato have […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Understanding gene-disease association via machine learning

DNA tales August 11, 2021August 10, 2021

Kanikah Mehndiratta, MSc, University of Glasgow Understanding the association between diseases and the potential genes involved can be challenging. Usually, scientists prefer biomedical experiments to explore the underlying genetics of a complex disease. But the experiments turn out to be very expensive and time consuming. They also pose risk for human error which can lead […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • World

New insulin treatment for Type 2 diabetes? Find out.

bioxone September 24, 2020September 24, 2020

Prama Ghosh, Amity University Kolkata Past information has shown that patients with type 2 diabetes would by and large lean toward fewer injections and more prominent adaptability than is typical of the current once-daily insulin treatment. Therefore, decreasing the number of injections might build acknowledgment of and adherence to insulin treatment among patients with type […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy